{"id":"https://openalex.org/W2762020603","doi":"https://doi.org/10.1093/ofid/ofx163.1464","title":"Evaluation of a Prolonged \u03b2-Lactam Antibiotic Infusion Policy on Clinical Outcomes in Patients with Pseudomonas aeruginosa Bacteremia","display_name":"Evaluation of a Prolonged \u03b2-Lactam Antibiotic Infusion Policy on Clinical Outcomes in Patients with Pseudomonas aeruginosa Bacteremia","publication_year":2017,"publication_date":"2017-01-01","ids":{"openalex":"https://openalex.org/W2762020603","doi":"https://doi.org/10.1093/ofid/ofx163.1464","mag":"2762020603"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofx163.1464","doi":"https://doi.org/10.1093/ofid/ofx163.1464","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofx163.1464","pdf_url":"https://academic.oup.com/ofid/article-pdf/4/suppl_1/S561/20430558/ofx163.1464.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/ofid/article-pdf/4/suppl_1/S561/20430558/ofx163.1464.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047982417","display_name":"Megan E. Barra","orcid":"https://orcid.org/0000-0002-7696-1540","observed_orcids":["https://orcid.org/0000-0002-7696-1540"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan E Barra","raw_affiliation_strings":["Department of Pharmacy, Brigham and Women\u2019s Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049615655","display_name":"Jillian Dempsey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jillian Dempsey","raw_affiliation_strings":["Department of Pharmacy, Brigham and Women\u2019s Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036083821","display_name":"Eleanor K. Broadbent","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eleanor Broadbent","raw_affiliation_strings":["Department of Pharmacy, Brigham and Women\u2019s Hospital, Boston, Massachusetts","Infectious Diseases , Mayo Clinic , Rochester , Minnesota ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]},{"raw_affiliation_string":"Infectious Diseases , Mayo Clinic , Rochester , Minnesota ;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038593102","display_name":"Nour Ismail","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nour Ismail","raw_affiliation_strings":["Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009030815","display_name":"Obadah Aloum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Obadah Aloum","raw_affiliation_strings":["Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091794017","display_name":"Paul M. Szumita","orcid":"https://orcid.org/0000-0002-3679-7037","observed_orcids":["https://orcid.org/0000-0002-3679-7037"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Szumita","raw_affiliation_strings":["Department of Pharmacy, Brigham and Women\u2019s Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Brigham and Women\u2019s Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042918956","display_name":"Sophia Koo","orcid":"https://orcid.org/0000-0002-4973-7439","observed_orcids":["https://orcid.org/0000-0002-4973-7439"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sophia Koo","raw_affiliation_strings":["Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008916094","display_name":"David W. Kubiak","orcid":"https://orcid.org/0000-0003-3133-0945","observed_orcids":["https://orcid.org/0000-0003-3133-0945"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David W Kubiak","raw_affiliation_strings":["Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"suppl_1","first_page":"S561","last_page":"S561"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa-bacteremia","display_name":"Pseudomonas aeruginosa bacteremia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/infusion-time","display_name":"infusion duration","score":0.5299999713897705},{"id":"https://openalex.org/keywords/ceftazidime","display_name":"ceftazidime","score":0.8199999928474426},{"id":"https://openalex.org/keywords/cefepime","display_name":"cefepime","score":0.9990000128746033},{"id":"https://openalex.org/keywords/icu-length-of-stay","display_name":"ICU length of stay","score":0.7799999713897705},{"id":"https://openalex.org/keywords/length-of-hospital-stay","display_name":"length of hospital stay","score":0.9959999918937683},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.9769999980926514},{"id":"https://openalex.org/keywords/practice-change","display_name":"practice change","score":0.5590000152587891},{"id":"https://openalex.org/keywords/gram-negative-bacteremia","display_name":"gram-negative bacteremia","score":0.5960000157356262},{"id":"https://openalex.org/keywords/antibiotic-dosing","display_name":"antibiotic dosing","score":0.37700000405311584}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9140892028808594},{"id":"https://openalex.org/C2779443120","wikidata":"https://www.wikidata.org/wiki/Q650912","display_name":"Bacteremia","level":3,"score":0.8855946660041809},{"id":"https://openalex.org/C2777050379","wikidata":"https://www.wikidata.org/wiki/Q2552927","display_name":"Cefepime","level":5,"score":0.8624544143676758},{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.5594503283500671},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.48012471199035645},{"id":"https://openalex.org/C2777080012","wikidata":"https://www.wikidata.org/wiki/Q3766250","display_name":"Mechanical ventilation","level":2,"score":0.4644681513309479},{"id":"https://openalex.org/C2776376669","wikidata":"https://www.wikidata.org/wiki/Q5094647","display_name":"Intensive care unit","level":2,"score":0.4426724910736084},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43338584899902344},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.4231640100479126},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3718418478965759},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.06665793061256409},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/ofid/ofx163.1464","doi":"https://doi.org/10.1093/ofid/ofx163.1464","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofx163.1464","pdf_url":"https://academic.oup.com/ofid/article-pdf/4/suppl_1/S561/20430558/ofx163.1464.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofx163.1464","doi":"https://doi.org/10.1093/ofid/ofx163.1464","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofx163.1464","pdf_url":"https://academic.oup.com/ofid/article-pdf/4/suppl_1/S561/20430558/ofx163.1464.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2762020603.pdf","grobid_xml":"https://content.openalex.org/works/W2762020603.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2989089762","https://openalex.org/W4413745681","https://openalex.org/W3034955587","https://openalex.org/W2150513758","https://openalex.org/W2314050702","https://openalex.org/W2099925865","https://openalex.org/W6902203216","https://openalex.org/W2756431720","https://openalex.org/W2074365649","https://openalex.org/W2461058310"],"abstract_inverted_index":{"Prolonged":[0,199],"\u03b2-lactam":[1,26,71,101,170,186,200],"antibiotic":[2,110],"infusions":[3,225],"achieve":[4],"superior":[5],"pharmacokinetic":[6],"and":[7,80,92,123,132,180,190],"pharmacodynamic":[8],"goals,":[9],"compared":[10,222],"with":[11,53,64,68,97,162,207,213,223,228],"intermittent":[12,224],"infusions.":[13],"In":[14,156],"October":[15],"2009,":[16],"our":[17,197],"institution":[18],"changed":[19],"the":[20,42,134,178],"standard":[21],"infusion":[22,201],"time":[23],"for":[24,138,147],"Gram-negative":[25],"antibiotics":[27],"from":[28,72],"30":[29],"minutes":[30],"to":[31,40,107,127],"3":[32,203],"hours.":[33],"The":[34,165],"objective":[35],"of":[36,44,90,115,184,192,211,220],"this":[37,45],"study":[38],"was":[39,171,194,205],"evaluate":[41],"effect":[43],"practice":[46,135],"change":[47],"on":[48,61],"clinical":[49,81,129],"outcomes":[50,82,130],"in":[51,176,196,226],"patients":[52,63,96,159,227],"Pseudomonas":[54],"aeruginosa":[55],"(PSA)":[56],"bacteremia.":[57,164,230],"We":[58,94,119],"collected":[59],"data":[60],"all":[62],"PSA":[65,103,163,229],"bacteremia":[66,99,150,193],"treated":[67],"an":[69,108],"intravenous":[70],"01/2004\u201312/2014,":[73],"including":[74],"demographics,":[75],"microbiology":[76,116],"results,":[77],"treatment":[78],"regimen,":[79],"such":[83],"as":[84,143],"intensive":[85],"care":[86],"unit":[87],"(ICU)/hospital":[88],"length":[89,210,219],"stay":[91,221],"mortality.":[93],"excluded":[95],"polymicrobial":[98],"or":[100],"resistant":[102],"that":[104],"required":[105],"switching":[106],"alternative":[109],"class":[111],"within":[112],"24":[113],"hours":[114,204],"susceptibility":[117],"results.":[118],"used":[120],"multivariable":[121],"linear":[122],"logistic":[124],"regression":[125],"analysis":[126],"compare":[128],"before":[131],"after":[133,188],"change,":[136],"adjusting":[137],"potential":[139],"confounders.":[140],"*Data":[141],"presented":[142],"median":[144],"(IQR)":[145],"#Adjusted":[146],"age,":[148],"Pitt":[149],"score,":[151],"ICU":[152,209],"admission,":[153],"mechanical":[154],"ventilation":[155],"total,":[157],"183":[158],"were":[160],"diagnosed":[161],"most":[166],"common":[167],"primary":[168],"anti-PSA":[169],"ceftazidime,":[172],"followed":[173],"by":[174],"cefepime,":[175],"both":[177],"pre":[179],"post-intervention":[181],"cohorts.":[182],"Development":[183],"new":[185],"resistance":[187],"therapy":[189],"recurrence":[191],"rare":[195],"cohort.":[198],"over":[202],"associated":[206],"decreased":[208,217],"stay,":[212],"a":[214],"trend":[215],"towards":[216],"hospital":[218],"D.":[231],"W.":[232],"Kubiak,":[233],"Shionogi:":[234],"Consultant,":[235,240],"Consulting":[236,241],"fee;":[237],"Astellas":[238],"Pharma:":[239],"fee":[242]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2017-10-20T00:00:00"}